Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies

Esther Vázquez, José L. Corchero, Joan F. Burgueño, Joaquin Seras-Franzoso, Ana Kosoy, Ramon Bosser, Rosa Mendoza, Joan Marc Martínez-Láinez, Ursula Rinas, Ester Fernández, Luis Ruiz-Avila, Elena García-Fruitõs*, Antonio Villaverde

*Autor corresponent d’aquest treball

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

66 Cites (Scopus)

Resum

Inclusion bodies (50-500 nm in diameter) produced in recombinant bacteria can be engineered to contain functional proteins with therapeutic potential. Upon exposure, these protein particles are efficiently internalized by mammalian cells and promote recovery from diverse stresses. Being fully biocompatible, inclusion bodies are a novel platform, as tailored nanopills, for sustained drug release in advanced cell therapies.

Idioma originalAnglès
Pàgines (de-a)1742-1747
Nombre de pàgines6
RevistaAdvanced Materials
Volum24
Número13
DOIs
Estat de la publicacióPublicada - 3 d’abr. 2012

Fingerprint

Navegar pels temes de recerca de 'Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies'. Junts formen un fingerprint únic.

Com citar-ho